Li Yu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Gastroesophageal Reflux Disease

Psychometric Properties

Top Venues

Therapeutic advances in respiratory disease

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Wanzhen Li, Tongyangzi Zhang, Wenhua Gu, Wenbo Shi, Shengyuan Wang, Yiqing Zhu, Cuiqin Shi, Li Yu, Xianghuai Xu
A comparison between a gastroesophageal reflux disease questionnaire-based algorithm and multichannel intraluminal impedance-pH monitoring for the treatment of gastroesophageal reflux-induced chronic cough. Therapeutic advances in respiratory disease 18 (2024)
Wanzhen Li, Tongyangzi Zhang, Wenhua Gu, Wenbo Shi, Shengyuan Wang, Yiqing Zhu, Cuiqin Shi, Li Yu, Xianghuai Xu
A comparison between a gastroesophageal reflux disease questionnaire-based algorithm and multichannel intraluminal impedance-pH monitoring for the treatment of gastroesophageal reflux-induced chronic cough. Therapeutic advances in respiratory disease 18 (2024)
Wanzhen Li, Tongyangzi Zhang, Wenhua Gu, Wenbo Shi, Shengyuan Wang, Yiqing Zhu, Cuiqin Shi, Li Yu, Xianghuai Xu
A comparison between a gastroesophageal reflux disease questionnaire-based algorithm and multichannel intraluminal impedance-pH monitoring for the treatment of gastroesophageal reflux-induced chronic cough. Therapeutic advances in respiratory disease 18 (2024)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Mengru Zhang, Alyn H Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. Therapeutic advances in respiratory disease 17 (2023)
Wei Chen, Junlu Wu, Weiwei Wang, Li Yu, Xianghuai Xu
PLAC8 Overexpression Promotes Lung Cancer Cell Growth via Wnt/ β -Catenin Signaling. Journal of immunology research 2022 (2022)
Ronglin Gao, Xianghuai Xu, Shengyuan Wang, Jincheng Pu, Cuiqin Shi, Siwan Wen, Yiqing Zhu, Jianping Tang, Xuan Wang, Li Yu
The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial. Trials 23 (1) (2022)
Hao Mei, Wenhua Gu, Linxin Ran, Siwan Wen, Li Yu, Xianghuai Xu
Evaluation methods and influencing factors of cough sensitivity. Therapeutic advances in respiratory disease 16 (2022)